Idecaptagene vecleucel (Ide-cel; bb2121), a BCMA-targeted CAR T cell therapy, in patients with relapsed and refractory multiple myeloma: initial KarMMa results - San Miguel, J; Shah, N; Oriol, A
EHA 2020; abstract S209